Ennogen Healthcare International Ltd. is focused on enhancing patient care through its diverse therapeutic areas, which include pain management, respiratory health, and dermatology. The company is dedicated to reinvigorating heritage brands to address unmet clinical needs, showcasing its commitment to innovation in the pharmaceutical and medical device sectors. With a strong international presence, Ennogen operates across Europe and other specific territories, leveraging its experienced management team to drive high performance and foster a collaborative environment that aligns with its core values.

In addition to its focus on patient care, Ennogen emphasizes sustainability as a critical component of its operations. The company has implemented a holistic sustainability strategy that prioritizes both environmental and social responsibilities, aiming to achieve Net Zero emissions by 2040. This commitment reflects Ennogen's understanding that fulfilling its purpose involves not only serving patients but also caring for the planet and empowering its workforce. Through these initiatives, Ennogen strives to make a positive impact on the communities it serves while continuing to grow as a leading player in the healthcare industry.

United Kingdom

Ennogen is a privately owned British company offering a range of medicines, medical devices, and unlicensed medicines. It was founded in 2011 by CEO John Ruprai.

Ennogen

Company Details